Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in-capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 26, 2020 90,934,930        
Beginning balance at Dec. 26, 2020 $ 364,587,000 $ 9,000 $ 565,815,000 $ (171,849,000) $ (29,388,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (8,970,000)     (8,970,000)  
Stock-based compensation     1,741,000    
Proceeds from exercise of stock options 1,643,000        
Hedging activity 0        
Change in cumulative foreign currency translation adjustment  $ 2,473,000       2,473,000
Ending balance (in shares) at Mar. 27, 2021 91,203,183        
Ending balance at Mar. 27, 2021 $ 361,474,000 $ 9,000 569,199,000 (180,819,000) (26,915,000)
Beginning balance (in shares) at Dec. 25, 2021   193,995,320      
Beginning balance at Dec. 25, 2021 1,150,095,000 $ 20,000 1,387,410,000 (210,181,000) (27,154,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (1,887,000)     (1,887,000)  
Stock-based compensation $ 6,018,000   6,018,000    
Proceeds from exercise of stock options (in shares) 268,253 52,694      
Proceeds from exercise of stock options $ 0   0    
Hedging activity 8,413,000        
Change in cumulative foreign currency translation adjustment  $ 3,735,000       3,735,000
Ending balance (in shares) at Mar. 26, 2022 194,048,014 194,048,014      
Ending balance at Mar. 26, 2022 $ 1,166,374,000 $ 20,000 $ 1,393,428,000 $ (212,068,000) $ (15,006,000)